Abstract Library

Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.

Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.

ENETS Abstract Search

#2028 Education and Preparation for Nuclear Medicine Procedures in Neuroendocrine Tumor Patients

Introduction: In 2007, a coalition of health care organizations formed around the a unified goal of improving imaging safety and quality for adults (Image Wisely) and children (Image Gently). In 2008, the Society of Nuclear Medicine (SNMMI) joined this coalition, embracing its role in providing outreach to the patient community. The Society has created an annual patient program to reach patients and caregivers, and is continually seeking input from the patient community to improve the program and other online educational resources.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Mailman J

Authors: Mailman J, Budzinski L,

Keywords: Imaging, Nuclear Medicine,

#1824 A Comparison of 68Ga-DOTA-TATE and 18F-FDG PET/CT Imaging on Patients with Pancreatic Neuroendocrine Neoplasm (pNEN)

Introduction: 68Ga-DOTA-TATE and 18F-FDG PET/CT are widely used for staging patients with pNEN.The sensitivity of nuclear modalities with pathologic correlation is unknown.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Zhang P

Authors: Zhang P, Yu J, Lu M, Shen L, Yang Z,

Keywords: pNEN,68Ga-DOTATATE,18F-FDG-PET,

#834 Nuclear Imaging in Intermediate Grade Neuroendocrine Tumors

Introduction: Early diagnosis and grading is essential to the treatment decision-making in neuroendocrine tumors. Conventionally, proliferation rate (Ki-67) level is used for the grading of NET. Ga-68 SMS-R PET/CT is the imaging method of choice for the detection of unknown primary neuroendocrine tumors. It is very sensitive in well-differentiated tumors (Ki-67 < 2%). Poorly and undifferentiated tumors having Ki-67 greater than 20% are primarily responsible for false negativity of Ga-68 SMS-R PET/CT. In those patients, FDG-PET is performed to localize the site of the primary tumor.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author:

Authors: Abou Yehia Z, Haydar A, Haydar M, Mukherji D, Temraz S,

Keywords: neuroendocrine tumors, nuclear imaging, histopathology ,

#317 Paraganglioma: Gallium-68 DOTOTATE PET CT Scanning, a Useful Addition to MIBG Scanning in Metastatic Disease

Introduction: Nuclear imaging forms an important part of the assessment of chromaffin cell tumors. MIBG scintigraphy has been available for some time, while 68Ga-DOTATATE PET CT is increasingly utilized.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Joharatnam J, Carroll R, Ghaffar A, Al-Nahhas A, Meeran K,

Keywords: phaeochromocytoma, paraganglioma, nuclear imaging, MIBG, Gallium-68 DOTATATE,

#29 Serum chromogranin A correlation with tumor burden in metastatic small bowel carcinoid patients

Introduction: Patients with neuroendocrine tumors may have clinical courses that range from fairly indolent to more aggressive. Cross–sectional studies, nuclear imaging and biochemical markers are often used to monitor disease progression. Optimal surveillance tests and intervals have not been firmly established. Studies suggest that chromogranin A (CgA) may be a surrogate marker for tumor burden.

Conference: 7th Annual ENETSConcerence (2010)

Presenting Author: Curran T

Authors: Schneiderman M, Curran T, Lee K, Warner R, Kim M,

Keywords: carcinoid, metastatic, biomarkers, radiology, chromogranin A,